About Us

HealO Medical, LLC, and HealOMed Scientific, Inc., are innovation-driven medical device companies of Medica360, LLC.

Headquartered in Sarasota, Florida, USA, Medica360’s teams collaborate across the US and Asia. Founder and CEO, Dr. Edward Lin, former Henry Woodburn Fellow - the most prestigious honor bestowed on PhD candidates - at the Roswell Park Cancer Institute, is board-certified anesthesiologist who trained at the Yale University School of Medicine.

Dr. Lin is the holder of multiple US and international patents and pending patent applications. Combining his clinical and scientific insight, manufacturing know-how and patent knowledge, Dr. Lin leads his team to create patent-protectable, clinically superior products that beat health-economics metrics.

In concert with HealO patent attorneys, Dr. Lin executes considered patent strategies that result in exceptional value to HealO’s investors. His patent prosecution record includes three appeals before the Patent Appeals Board and one re-examination, and successful outcome every time.

Management Team

Dr. Edward Lin, Founder and CEO

Ed is a Yale-trained board-certified anesthesiologist, biomedical scientist and inventor, He is a proactive positive thinker and polymath who applies creativity and perseverance to attain uncommon results, including national recognition for his innovations and appealing patent application rejections three times before the Patent Trial and Appeal Board in the US and overseas and winning every time. Ed was Chairman of Anesthesiology at an Ohio hospital and Associate Professor of anesthesiology at Ohio U. He was also trained in internal and emergency medicine and was Henry Woodburn Fellow at Roswell Park Cancer Institute, the highest honor bestowed by SUNY at Buffalo Graduate School of Biomedical Sciences. He is the founder of Ingenious Technologies and has successfully commercialized some of his inventions, including a Class II medical device.

Bryan Lin, V.P. of Operations

Bryan is an accomplished industrial engineering, project management, business analytics, & supply chain management professional, with more than a decade-record of high-profile achievements featuring systems engineering, analytics, and performance improvement in the retail, manufacturing, healthcare, medical device, and defense industries. Bryan holds Master’s degrees in Industrial Engineering and Business Administration and is a Certified Lean Six Sigma Black Belt and Project Management Professional.

Elsa Abruzzo, RAC, FRAPS, Director of Regulatory Affairs

Elsa is a biotech and medical device expert, and the founding partner of the consulting firm, Cygnus Regulatory with a 30+ year successful regulatory, quality, and clinical track record. Her work included transcatheter heart valves (TAVR), implantable biomaterials, surgical adhesives, embolic agents, stents and cardiac ablation devices. Elsa managed clinical trials and led regulatory strategies at companies such as Baxter, Cordis JNJ, CryoLife, etc. She has a B.S. in engineering from the University of Miami and is regulatory affairs certified (RAC) and a Regulatory Affairs Professional Society (RAPS) Fellow.

Hasnaa Fatehi, PhD, RAC

A RAPS-certified Regulatory Affairs Professional and a BSI-certified 13485:2016 Lead Auditor, Hasnaa has served as a Regulatory and Quality Assurance Manager in both multinational corporations and start-ups. Her diverse experience includes QMS establishment, implementation and maintenance, and pre-market and post-market regulatory compliance for low to medium risk devices in Europe, U.S., Canada and Australia/New Zealand. Hasnaa studied and worked in Europe, North America and Asia.

Advisory Board

David Armstrong, DPM, MD, PhD

A Professor of Surgery at the University of Southern California and founder and co-Director of the Southwestern Academic Limb Salvage Alliance (SALSA), Dr. Armstrong has produced more than 460 peer-reviewed research papers in dozens of scholarly medical journals as well as over 80 book chapters. He is co-Editor of the American Diabetes Association’s (ADA) Clinical Care of the Diabetic Foot, now in its third edition. Among Dr. Armstrong’s many accolades include selection as one of the first six International Wound Care Ambassadors, recipient of the inaugural Georgetown Distinguished Award for Diabetic Limb Salvage, and youngest-ever member elected into the Podiatric Medicine Hall of Fame and youngest-ever recipient of the ADA’s Roger Pecoraro Lifetime Achievement Award.

H. Peter Lorenz, MD

Dr. Lorenz is Professor of Plastic & Reconstructive surgery, Stanford University Medical Center; Chief of Pediatric Plastic Surgery, Stanford Medical Center; Director of NIH-funded Hagey Laboratory for Pediatric Regenerative Medicine; author of numerous research publications. Dr. Lorenz was a founder of Stem Source, Inc., which is now part of the public company, Cytori Therapeutics. He is a nationally recognized authority on wound care and is a member of Bio-X, Stanford’s pioneering interdisciplinary biosciences institute

Abraham Xiong, CCM

Mr. Xiong is the Founder and President of the Government Contractors Association where he has trained more than 12,000 businesses and assisted them in winning over $900 million in government contracts. He is a Co-Founder of the Blockchain Chamber of Commerce, GovGenie.com, and several other enterprises. He is a social entrepreneur, executive trainer, blockchain ambassador, technology enthusiast, business coach, community leader and small business advocate. Mr. Xiong is the recipient of President Obama’s Lifetime Achievement Award, Georgia’s Goodwill Ambassador Award, and the Global Humanitarian Award.

Joseph Hage, MBA

Mr. Hage is the Founder and CEO of Medical MarComm, a medical industry consultancy. A former executive of Cardiac Science, Mr. Hage heads the Medical Device Group, the world’s largest organization for medical device professionals on LinkedIn, with over 340,000 members. Joe is well versed in issues affecting the medical device industry and possesses a wealth of executive marketing experience in both medical devices and consumer industries.